Tarsus Targets Initial Small Segment Of Blepharitis Population With Xdemvy Approval

 
• By Alaric DeArment
  
Tarsus announced the approval of Xdemvy for blepharitis caused by Demodex mites • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip